Literature DB >> 8083599

HIV-1 entry and reverse transcription in macrophages.

W A O'Brien1.   

Abstract

Although CD4 is required for efficient virus entry, it is not sufficient for entry of all primary HIV-1 strains. There may be additional virus-cell interactions, possibly involving the V3 region of the extracellular envelope protein, gp120, that occur following conformational changes induced by CD4 binding. This second interaction would precede fusion events and entry of the virus core. Primary HIV-1 strains appear to have a higher virion envelope density and retain gp120 better than HIV-1 strains adapted to growth in T cell lines in culture. These properties may confer a growth advantage in vivo to primary strains on the basis of less well exposed CD4 binding and neutralization domains. HIV-1 entry into both activated and quiescent T cells, as well as macrophages, is efficient for most primary strains, but there are different patterns of reverse transcription. Productive infection of activated T cells is associated with cell proliferation and accumulation of full-length reverse transcripts within 4 to 6 h. In resting, nondividing T cells, reverse transcription is aborted prior to full-length viral DNA formation. A third pattern of reverse transcription is seen in nondividing cultured macrophages with slow kinetics and accumulation of full-length viral DNA between 36 and 48 h. This rate can be increased by adding exogenous nucleotides, but still not to the rate seen in activated T cells. Future antiretroviral therapies may involve interference with cell-specific functions involved in reverse transcription.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083599     DOI: 10.1002/jlb.56.3.273

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  14 in total

Review 1.  Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction.

Authors:  K Grovit-Ferbas; M E Harris-White
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

2.  Broad-spectrum anti-human immunodeficiency virus (HIV) potential of a peptide HIV type 1 entry inhibitor.

Authors:  Simon Cocklin; Hosahudya Gopi; Bianca Querido; Manideepthi Nimmagadda; Syna Kuriakose; Claudia Cicala; Sandya Ajith; Sabine Baxter; James Arthos; Julio Martín-García; Irwin M Chaiken
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

3.  Characterization of the behavior of functional viral genomes during the early steps of human immunodeficiency virus type 1 infection.

Authors:  Vanessa Arfi; Julia Lienard; Xuan-Nhi Nguyen; Gregory Berger; Dominique Rigal; Jean-Luc Darlix; Andrea Cimarelli
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

Review 4.  Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation.

Authors:  Sonia Shah; Michael R Nonnemacher; Vanessa Pirrone; Brian Wigdahl
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

5.  Infrequent HIV Infection of Circulating Monocytes during Antiretroviral Therapy.

Authors:  Marta Massanella; Wendy Bakeman; Pasiri Sithinamsuwan; James L K Fletcher; Nitiya Chomchey; Somporn Tipsuk; Thep Chalermchai; Jean-Pierre Routy; Jintanat Ananworanich; Victor G Valcour; Nicolas Chomont
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

6.  Restricted 5'-end gap repair of HIV-1 integration due to limited cellular dNTP concentrations in human primary macrophages.

Authors:  Sarah K Van Cor-Hosmer; Dong-Hyun Kim; Michele B Daly; Waaqo Daddacha; Baek Kim
Journal:  J Biol Chem       Date:  2013-10-04       Impact factor: 5.157

Review 7.  Cellular reservoirs of HIV-1 and their role in viral persistence.

Authors:  Aikaterini Alexaki; Yujie Liu; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2008-09       Impact factor: 1.581

8.  The effect of different immune responses on the evolution of virulent CXCR4-tropic HIV.

Authors:  D Wodarz; M A Nowak
Journal:  Proc Biol Sci       Date:  1998-11-22       Impact factor: 5.349

9.  Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle.

Authors:  Ahmad R Sedaghat; Jason B Dinoso; Lin Shen; Claus O Wilke; Robert F Siliciano
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-24       Impact factor: 11.205

10.  Low levels of HIV-1 infection in cutaneous dendritic cells promote extensive viral replication upon binding to memory CD4+ T cells.

Authors:  M Pope; S Gezelter; N Gallo; L Hoffman; R M Steinman
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.